Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 0.1 | 16.1 | 0.4 |
| Revenue growth | -99.5% | 3849.1% | |
| Cost of goods sold | 5.6 | -4.6 | 4.6 |
| Gross profit | -5.5 | 20.6 | -4.1 |
| Gross margin | -7330.7% | 128.3% | -1018.7% |
| Research and development | 3.3 | 1.7 | 1.7 |
| General and administrative | 11.7 | 4.1 | 3.3 |
| EBIT | -20.4 | 5.7 | -9.1 |
| EBIT margin | -27249.3% | 35.7% | -2237.8% |
| Pre-tax income | -20.5 | 2.2 | -11.7 |
| Income taxes | -0.2 | -0.1 | -0.1 |
| Tax rate | 0.7% | | 0.6% |
| Net income | 0.0 | 0.0 | 0.0 |
| Net margin | 0.0% | 0.0% | 0.0% |
| |
| Diluted EPS | $0.00 | | |
| Shares outstanding (diluted) | 0.0 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|